Yu-Hong Li, Yi-Fu He, Wen-Qi Jiang, Fen-Hua Wang, Xu-Bin Lin, Li Zhang, Zhong-Jun Xia, Xiao-Fei Sun, Hui-Qiang Huang, Tong-Yu Lin, You-Jian He and Zhong-Zhen Guan Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma Cancer 106
Version of Record online: 8 FEB 2006 | DOI: 10.1002/cncr.21701
The authors assessed the value of antiviral lamivudine in reducing the incidence and severity of hepatitis in hepatitis B virus (HBV) carriers with lymphoma who were receiving chemotherapy. The results showed that lamivudine prophylaxis significantly reduced the incidence and severity of hepatitis in HBV carriers who received chemotherapy for lymphoma, and the chemotherapy disruption rate also decreased significantly.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field